Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
atlas venture
2
×
biotech
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
allosteric
astellas pharma
atopic dermatitis
audentes therapeutics
autoimmune disorders
avidity biosciences
bluebird bio
brace pharma
cleva pharma
deals
drug discovery
duchenne muscular dystrophy
dupilumab
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
glaxosmithkline
hotspot therapeutics
investing
jonathan montagu
joshua brumm
kaleido biosciences
metabolic diseases
mrl ventures fund
muscular dystrophy
myotonic dystrophy type 1
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
What
ago
medicines
2
×
therapeutics
2
×
address
adds
allosteric
biotechs
clinic
considering
data
disease
diseases
drug
dyne
early
elusive
expected
experimental
eyes
genetic
having
hotspot
humans
ipo
ipos
long
molecules
muscle
new
path
potential
rare
reach
set
steer
targets
ways
worked
years
Language
unset
Current search:
medicines
×
therapeutics
×
" atlas venture "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic